查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球药物滥用治疗市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测
市场调查报告书
商品编码
1305286

全球药物滥用治疗市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测

Global Substance Abuse Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格

药物滥用治疗市场的全球需求预计将从2022年的118.9亿美元增长到2030年的近267.6亿美元，2023-2030年的复合年增长率为10.67%。

药物滥用治疗是指一系列用于帮助个人克服药物或酒精成瘾的干预和疗法。药物滥用治疗涉及不同的方法，包括行为疗法、药物辅助治疗和支持小组。行为疗法包括帮助个人改变与吸毒或酗酒有关的态度和行为。这些疗法可以在个人或团体环境中进行，可能包括认知行为疗法、动机访谈和应急管理。药物辅助治疗包括使用美沙酮、丁丙诺啡和纳曲酮等药物来减少与成瘾相关的渴求和戒断症状。这些药物通常与行为疗法结合使用。

市场动态：

包括阿片类药物成瘾在内的药物滥用疾病发病率不断上升，推动了对药物滥用治疗服务的需求。各国政府正在实施相关政策和倡议，以应对阿片类药物的流行并增加药物滥用治疗服务的可及性。美国药物滥用和精神健康服务管理局（SAMHSA）为药物滥用治疗项目提供资金支持。药物滥用治疗的新药物和新疗法的开发取得了进展。丁丙诺啡（buprenorphine）和纳曲酮（naltrexone）等药物已被证明可有效治疗阿片类药物成瘾，而认知行为疗法（cognitive-behavioral therapy）和动机访谈（motivational interviewing）等行为疗法也很有效。人们越来越意识到并接受药物滥用障碍是一种需要治疗的疾病。这减少了与寻求治疗相关的耻辱感，增加了对药物滥用治疗服务的需求。人们对门诊药物滥用治疗服务的需求日益增长，这种服务允许患者在接受治疗的同时继续工作或上学，从而促进了更多门诊治疗项目的发展，增加了获得治疗的机会。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构，评估全球范围内的竞争吸引力。此外，这些工具还对全球药物滥用治疗市场的各个细分市场进行了全面评估。药物滥用治疗行业的增长和趋势为本研究提供了全面的方法。

市场细分：

药物滥用治疗市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按治疗类型

  • 烟草/尼古丁和吸烟
  • 酒精类
  • 大麻
  • 合成大麻素
  • 处方药和非处方药
  • 其他

按最终用途分类

  • 医院
  • 诊所
  • 康复中心
  • 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美、中东和非洲地区药物滥用治疗市场的当前和未来需求。此外，报告还重点关注了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。药物滥用治疗市场的主要参与者包括Teva Pharmaceutical Industries Ltd.、Abbott、GSK plc.、Cipla Inc.、Lilly (Eli Lilly and Company)、Novartis AG、Sun Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories Ltd.、Viatris Inc.、AstraZeneca。本部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

如果您有任何定制要求，请联系我们。我们的研究团队可以根据您的需求提供定制报告。

目 录

第一章：前言

  • 报告描述
    • 报告目标
    • 目标受众
    • 独特销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章：执行摘要

  • 市场亮点
  • 全球市场概况

第三章：药物滥用治疗-行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按治疗类型分類的市场吸引力分析
    • 按最终用途的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章：全球药物滥用治疗市场分析：按治疗类型划分

  • 治疗类型概述
  • 历史和预测数据
  • 按治疗类型分析
  • 烟草/尼古丁和吸烟
  • 酒精类
  • 大麻
  • 合成大麻素
  • 处方药和非处方药
  • 其他

第6章：全球药物滥用治疗市场分析：按最终用途分类

  • 按最终用途概述
  • 历史和预测数据
  • 按最终用途分析
  • 医院
  • 诊所
  • 康复中心
  • 其他

第七章 ：全球药物滥用治疗市场分析：按地域划分

  • 地区展望
  • 地区介绍
  • 北美销售分析
    • 概述、历史和预测数据 销售分析
    • 北美地区销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据 销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据 销售分析
    • 亚太地区细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据 销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据 销售分析
    • 中东及非洲地区销售分析
    • 中东及非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第八章 : 药物滥用治疗企业的竞争格局

  • 药物滥用治疗市场竞争
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品上市
  • 其他发展

第九章 : 公司概况

  • 顶级公司市场份额分析
  • 市场集中度
  • Teva Pharmaceutical Industries Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Abbott
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • GSK plc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Cipla Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Lilly (Eli Lilly and Company)
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Sun Pharmaceutical Industries Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Dr. Reddy's Laboratories Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Viatris Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • AstraZeneca
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

Product Code: VMR112110780

The global demand for Substance Abuse Treatment Market is presumed to reach the market size of nearly USD 26.76 BN by 2030 from USD 11.89 BN in 2022 with a CAGR of 10.67% under the study period 2023 - 2030.

Substance abuse treatment refers to a range of interventions and therapies that are used to help individuals overcome addiction to drugs or alcohol. Substance abuse treatment can involve different approaches, including behavioral therapies, medication-assisted treatment, and support groups. Behavioral therapies involve helping individuals to modify their attitudes and behaviors related to drug or alcohol use. These therapies can be delivered in individual or group settings and may include cognitive-behavioral therapy, motivational interviewing, and contingency management. Medication-assisted treatment involves the use of medications such as methadone, buprenorphine, and naltrexone to reduce cravings and withdrawal symptoms associated with addiction. These medications are often used in conjunction with behavioral therapies.

Market Dynamics:

The increasing prevalence of substance abuse disorders, including opioid addiction, is driving the demand for substance abuse treatment services. Governments are implementing policies and initiatives to address the opioid epidemic and increase access to substance abuse treatment services. The Substance Abuse and Mental Health Services Administration (SAMHSA) in the United States provides funding for substance abuse treatment programs. There have been advancements in the development of new medications and therapies for substance abuse treatment. Medications such as buprenorphine and naltrexone have been shown to be effective in treating opioid addiction, while behavioral therapies such as cognitive-behavioral therapy and motivational interviewing have also been effective. There is increasing awareness and acceptance of substance abuse disorders as a medical condition that requires treatment. This has reduced the stigma associated with seeking treatment and increased the demand for substance abuse treatment services. There is a growing demand for outpatient substance abuse treatment services, which allow individuals to receive treatment while continuing to work or attend school leading to the development of more outpatient treatment programs and increased access to care.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of substance abuse treatment. The growth and trends of substance abuse treatment industry provide a holistic approach to this study.

Market Segmentation:

This section of the substance abuse treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

  • Tobacco/Nicotine And Vaping
  • Alcohol
  • Marijuana
  • Synthetic Cannabinoids
  • Prescription And Over-The-Counter Medications
  • Others

By End-Use

  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Substance Abuse Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the substance abuse treatment market include Teva Pharmaceutical Industries Ltd., Abbott, GSK plc., Cipla Inc., Lilly (Eli Lilly and Company), Novartis AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Viatris Inc., AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SUBSTANCE ABUSE TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Treatment Type
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SUBSTANCE ABUSE TREATMENT MARKET ANALYSIS BY TREATMENT TYPE

  • 5.1 Overview by Treatment Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Treatment Type
  • 5.4 Tobacco/Nicotine And Vaping Historic and Forecast Sales by Regions
  • 5.5 Alcohol Historic and Forecast Sales by Regions
  • 5.6 Marijuana Historic and Forecast Sales by Regions
  • 5.7 Synthetic Cannabinoids Historic and Forecast Sales by Regions
  • 5.8 Prescription And Over-the-counter Medications Historic and Forecast Sales by Regions
  • 5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL SUBSTANCE ABUSE TREATMENT MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-use
  • 6.4 Hospitals Historic and Forecast Sales by Regions
  • 6.5 Clinics Historic and Forecast Sales by Regions
  • 6.6 Rehabilitation Centers Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL SUBSTANCE ABUSE TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE SUBSTANCE ABUSE TREATMENT COMPANIES

  • 8.1. Substance Abuse Treatment Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF SUBSTANCE ABUSE TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Teva Pharmaceutical Industries Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Abbott
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. GSK plc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Cipla Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Lilly (Eli Lilly and Company)
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Novartis AG
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Sun Pharmaceutical Industries Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Dr. Reddy's Laboratories Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Viatris Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. AstraZeneca
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Treatment Type (USD MN)
  • Tobacco/Nicotine And Vaping Market Sales by Geography (USD MN)
  • Alcohol Market Sales by Geography (USD MN)
  • Marijuana Market Sales by Geography (USD MN)
  • Synthetic Cannabinoids Market Sales by Geography (USD MN)
  • Prescription And Over-the-counter Medications Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Rehabilitation Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Substance Abuse Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Substance Abuse Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Substance Abuse Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Treatment Type (USD MN)
  • Tobacco/Nicotine And Vaping Market Sales by Geography (USD MN)
  • Alcohol Market Sales by Geography (USD MN)
  • Marijuana Market Sales by Geography (USD MN)
  • Synthetic Cannabinoids Market Sales by Geography (USD MN)
  • Prescription And Over-the-counter Medications Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Rehabilitation Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.